Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-004000
Filing Date
2025-02-14
Accepted
2025-02-14 16:14:24
Documents
84
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K krbp20241231_10k.htm   iXBRL 10-K 2003526
2 EXHIBIT 23.1 ex_707621.htm EX-23.1 2617
3 EXHIBIT 31.1 ex_707622.htm EX-31.1 12315
4 EXHIBIT 31.2 ex_707623.htm EX-31.2 12501
5 EXHIBIT 32.1 ex_707624.htm EX-32.1 5185
6 EXHIBIT 32.2 ex_707625.htm EX-32.2 5222
12 evaluate01.jpg GRAPHIC 82458
13 p01.jpg GRAPHIC 57806
14 slide02.jpg GRAPHIC 68758
15 slide03.jpg GRAPHIC 41378
16 slide04.jpg GRAPHIC 61469
  Complete submission text file 0001437749-25-004000.txt   8477720

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA krbp-20241231.xsd EX-101.SCH 63993
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krbp-20241231_cal.xml EX-101.CAL 40907
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krbp-20241231_def.xml EX-101.DEF 415872
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE krbp-20241231_lab.xml EX-101.LAB 351578
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krbp-20241231_pre.xml EX-101.PRE 450595
87 EXTRACTED XBRL INSTANCE DOCUMENT krbp20241231_10k_htm.xml XML 1161464
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39619 | Film No.: 25628874
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)